Resumo

MACHADO-ALBA, Jorge E; MARTINEZ-PULGARIN, Dayron F  e  GOMEZ-SUTA, Daniela. Prevalence of potential drug interactions with azithromycin in Colombia, 2012-2013. Rev. salud pública [online]. 2015, vol.17, n.3, pp.463-469. ISSN 0124-0064.  https://doi.org/10.15446/rsap.v17n3.44142.

Objective To determine the prevalence of potential drug interactions between azithromycin and different IA and III antiarrhythmic groups in a national database of drug prescriptions in 2012-2013. Methods Retrospective study based on a population database of medicine dispensation. Data from patients who received azithromycin between January 1, 2012 and June 30, 2013 were extracted along with data from patients who received azithromycin in combination with other medications shown to cause heart arrhythmias when used concomitantly. Frequencies and proportions were established. Results 13 859 patients receiving azithromycin alone or in combination with other drugs were identified. The average time of use was 4.5 ± 0.9 days. A total of 702 patients (5.1 %) received azithromycin plus 19 other potentially risky drugs. The most frequently associated were loratadine (77.1 %), diphenhydramine (16.5 %) and amitriptyline (8.1 %). Combinations with a single drug were the most frequent (n=533, 75.9 %), predominantly azithromycin+loratadine. The maximum number of combined drugs was six (n=2, 0.3 %). Conclusions Identification of drug prescriptions through population databases is an effective way to find potential drug interactions. The frequency of potential interactions between azithromycin and other drugs is common in Colombian patients. Future research should assess the risk of occurrence of adverse cardiac events.

Palavras-chave : Azithromycin; drug interactions; anti-arrhythmia agents; Pharmacoepidemiology.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )